28 Apr 2025 14:30 CEST

Reference is made to the announcement by IDEX Biometrics ASA (the "Company") on
11 March 2025 regarding a loan financing of NOK 30 million and a proposed debt
conversion of the loan. Reference is also made to the announcement on 11 April
2025 regarding the resolution by the Extraordinary General Meeting to carry out
the debt conversion by issuance of a total of 3,000,000,000 new shares in the
Company.

The share capital increase by debt conversion has duly been registered in the
Norwegian Register of Business Enterprises. Following the share capital
increase, the Company's share capital is NOK 38,315,942.32 divided into
3,831,594,232 shares, each with a nominal value of NOK 0.01.

For further information, please contact:

Kristian Flaten, CFO, Tel: +47 95092322

E-mail: ir@idexbiometrics.com (mailto:ir@idexbiometrics.com)


About IDEX Biometrics:

IDEX Biometrics ASA (IDEX) is a global technology leader in fingerprint
biometrics, offering authentication solutions across payments, access control,
and digital identity. Our solutions bring convenience, security, peace of mind
and seamless user experiences to the world. Built on patented and proprietary
sensor technologies, integrated circuit designs, and software, our biometric
solutions target card-based applications for payments and digital
authentication. As an industry-enabler we partner with leading card
manufacturers and technology companies to bring our solutions to market. For
more information, visit www.idexbiometrics.com

About this notice:

This notice was published by Kristian Flaten, CFO, 28 April 2025 at 14:30 CET on
behalf of IDEX Biometrics ASA.  This information is subject to the disclosure
requirements pursuant to the Norwegian Securities Trading Act section 5-12.


Source

IDEX Biometrics ASA

Provider

Oslo Børs Newspoint

Company Name

IDEX BIOMETRICS

ISIN

NO0013107490, NO0013536078

Symbol

IDEX

Market

Euronext Oslo Børs